PRNewsWire
11 Aug 2026, 10:30 UTC · 1h ago
DarioHealth Reports Second Quarter 2026 Financial Results
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

PRNewsWire
11 Aug 2026, 10:30 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
DarioHealth successfully completed a $23.5 million registered direct financing following the second quarter. — Immediate liquidity injection strengthens the balance sheet and reduces near-term insolvency risk for a loss-making company.
+0.60Quarterly revenue declined to $5.2 million from $5.4 million year-over-year and $5.6 million sequentially. — Top-line contraction suggests challenges in scaling the B2B2C model despite the transition away from one-time pharmaceutical revenue.
-0.40Gross margin increased to 61.7% from 55.2% year-over-year, aided by an IEEPA tariff refund. — Improved margins indicate better operational efficiency, though the impact is partially inflated by a one-time tax refund.
+0.30Continue reading
6 related stories
Top 2 movers · tap to explore
Net loss improved to $7.9 million compared to $13.0 million in the same period last year. — Reduced burn rate shows positive progress toward profitability, though the company remains substantially loss-making.
+0.20Which stocks this story touches
The company reported improved gross margins and a reduced net loss year-over-year, alongside a successful $23.5 million financing round.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
2h ago